Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05359965 · ClinicalTrials.gov registry record · NA
Effect of CPAP on Abnormal Gastroesophageal Reflux and Lung Inflammation in IPF
A NA study, sponsored by University of Arizona.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT05359965 is a NA study that was terminated before completion, run by University of Arizona. The registered enrollment target is 7 participants.
The verdict
NCT05359965, a NA study, was terminated before completion, sponsored by University of Arizona.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study will evaluate the effect of CPAP therapy on esophageal pH and lung inflammation in patients with idiopathic pulmonary fibrosis (IPF) and sleep apnea.
Interventions
- DEVICE Positive Airway Pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2025-02-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05359965
The ClinicalTrials.gov registry entry for NCT05359965 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Positive Airway Pressure is the first listed.
NCT05359965 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05359965 about?
NCT05359965 is a clinical study titled "Effect of CPAP on Abnormal Gastroesophageal Reflux and Lung Inflammation in IPF". This study will evaluate the effect of CPAP therapy on esophageal pH and lung inflammation in patients with idiopathic pulmonary fibrosis (IPF) and sleep apnea.
What is the current status of trial NCT05359965?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2019-10-01. Estimated completion is 2025-02-11.
What interventions are being tested in trial NCT05359965?
The interventions under investigation include: Positive Airway Pressure (DEVICE).
Who is sponsoring clinical trial NCT05359965?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.